These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Transmission of viruses (from A to E) and prevention]. Jouanolle H; Brissot P Rev Prat; 1990 Jun; 40(18):1660-6. PubMed ID: 2115202 [TBL] [Abstract][Full Text] [Related]
5. Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 – conclusions and recommendations. Wkly Epidemiol Rec; 2016 Dec; 91(48):561-82. PubMed ID: 27922031 [No Abstract] [Full Text] [Related]
6. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178 [No Abstract] [Full Text] [Related]
7. Virology Downunder, a meeting commentary from the 2019 Lorne Infection and Immunity Conference, Australia. Ebert G; Paradkar PN; Londrigan SL Virol J; 2019 Sep; 16(1):109. PubMed ID: 31477134 [TBL] [Abstract][Full Text] [Related]
8. [12th Congress of Virology of Versailles-Le Chesnay. 20, 21 May 1999]. Pinon G Ann Biol Clin (Paris); 1999; 57(5):627-30. PubMed ID: 10577288 [No Abstract] [Full Text] [Related]
9. Summary of the 9th annual meeting of the Italian Society for Virology. Salata C; Calistri A; Parolin C; Palù G J Cell Physiol; 2011 Jan; 226(1):285-7. PubMed ID: 20799282 [TBL] [Abstract][Full Text] [Related]
10. Development of working reagents and international standards. Saldanha J Biologicals; 1998 Jun; 26(2):115-7. PubMed ID: 9811516 [No Abstract] [Full Text] [Related]
11. DNA-vaccines against hepatitis B and C viral infections: a brief overview. Irshad M Trop Gastroenterol; 1999; 20(2):64-7. PubMed ID: 10484889 [No Abstract] [Full Text] [Related]
12. What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States? Buckley GJ; Strom BL Ann Intern Med; 2016 Aug; 165(4):284-5. PubMed ID: 27064885 [No Abstract] [Full Text] [Related]
13. [Seroprevalence of hepatitis B and C viruses in a psychiatric institution]. Eveillard M; Daroukh A; Desjardins P; Legrand S; Odzo-Gakala M; Bourlioux P Pathol Biol (Paris); 1999 May; 47(5):543-8. PubMed ID: 10418037 [TBL] [Abstract][Full Text] [Related]
14. The prophylactic and therapeutic uses of immunoglobulin in virus infections. Miller DL Mod Trends Med Virol; 1970; 2(0):284-309. PubMed ID: 4134758 [No Abstract] [Full Text] [Related]
15. [National control plan for hepatitis B and C, 2009-2012: public health issues]. Lavin L; Faliu B; Bessa Z; Houssin D Rev Prat; 2011 Jan; 61(1):8-9. PubMed ID: 21452532 [No Abstract] [Full Text] [Related]
16. Immunization against infectious disease. Olshin IJ Compr Ther; 1984 Jun; 10(6):13-9. PubMed ID: 6734129 [No Abstract] [Full Text] [Related]
17. Vaccination against hepatitis B and C: towards therapeutic application. Inchauspe G; Bach G; Martin P; Bonnefoy JY Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251 [No Abstract] [Full Text] [Related]
18. [Current perspectives in virology: prevention]. Maass G Immun Infekt; 1993 Dec; 21(6):177-9. PubMed ID: 8144183 [TBL] [Abstract][Full Text] [Related]
19. [When are which vaccinations indicated? Basic immunization--polio-diphtheria-hepatitis B]. Maass G Fortschr Med; 1996 Nov; 114(32):17-20. PubMed ID: 9064262 [No Abstract] [Full Text] [Related]
20. Meeting of the immunization Strategic Advisory Group of Experts, November 2008--conclusions and recommendations. Wkly Epidemiol Rec; 2009 Jan; 84(1-2):1-16. PubMed ID: 19149014 [No Abstract] [Full Text] [Related] [Next] [New Search]